avapro has been researched along with Diabetic Cardiomyopathies in 2 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Myocardial fibrosis is one of the serious pathological changes, so investigating the pathogenesis of myocardial fibrosis has the significant value." | 1.51 | Effect of Irbesartan on AGEs-RAGE and MMPs systems in rat type 2 diabetes myocardial-fibrosis model. ( Guanjun, Z; Heng, Z; Hongwei, Y; Jie, H; Jie, T; Junfeng, H; Qin, G; Ruiping, C; Xingyu, L; Yingyan, F; Zhenghong, L, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hongwei, Y | 1 |
| Ruiping, C | 1 |
| Yingyan, F | 1 |
| Guanjun, Z | 1 |
| Jie, H | 1 |
| Xingyu, L | 1 |
| Jie, T | 1 |
| Zhenghong, L | 1 |
| Qin, G | 1 |
| Junfeng, H | 1 |
| Heng, Z | 1 |
| Liu, X | 1 |
| Xu, Q | 1 |
| Wang, X | 1 |
| Zhao, Z | 1 |
| Zhang, L | 1 |
| Zhong, L | 1 |
| Li, L | 1 |
| Kang, W | 1 |
| Zhang, Y | 1 |
| Ge, Z | 1 |
2 other studies available for avapro and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Effect of Irbesartan on AGEs-RAGE and MMPs systems in rat type 2 diabetes myocardial-fibrosis model.
Topics: Animals; Blood Glucose; Body Weight; Collagen; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; | 2019 |
Irbesartan ameliorates diabetic cardiomyopathy by regulating protein kinase D and ER stress activation in a type 2 diabetes rat model.
Topics: Animals; Biphenyl Compounds; Cardiotonic Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, | 2015 |